Michigan Medicine: 2 Multiple Myeloma Treatments Receive FDA Approval
February 13, 2026
February 13, 2026
ANN ARBOR, Michigan, Feb. 13 -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following Q&A on Feb. 12, 2026, by Ananya Sen with Matthew Pianko, clinical associate professor of internal medicine:
* * *
2 multiple myeloma treatments receive FDA approval
An expert answers questions about linvoseltamab and daratumumab, which were tested through Michigan Medicine clinical trials
*
Multiple . . .
* * *
2 multiple myeloma treatments receive FDA approval
An expert answers questions about linvoseltamab and daratumumab, which were tested through Michigan Medicine clinical trials
*
Multiple . . .